These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32669438)

  • 1. A cocrystal structure of dengue capsid protein in complex of inhibitor.
    Xia H; Xie X; Zou J; Noble CG; Russell WK; Holthauzen LMF; Choi KH; White MA; Shi PY
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17992-18001. PubMed ID: 32669438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
    Anasir MI; Ramanathan B; Poh CL
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions.
    Smith JL; Sheridan K; Parkins CJ; Frueh L; Jemison AL; Strode K; Dow G; Nilsen A; Hirsch AJ
    Antiviral Res; 2018 Jul; 155():12-19. PubMed ID: 29709563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Functional Properties of the Capsid Protein of Dengue and Related
    Faustino AF; Martins AS; Karguth N; Artilheiro V; Enguita FJ; Ricardo JC; Santos NC; Martins IC
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inhibitor of dengue virus replication that targets the capsid protein.
    Byrd CM; Dai D; Grosenbach DW; Berhanu A; Jones KF; Cardwell KB; Schneider C; Wineinger KA; Page JM; Harver C; Stavale E; Tyavanagimatt S; Stone MA; Bartenschlager R; Scaturro P; Hruby DE; Jordan R
    Antimicrob Agents Chemother; 2013 Jan; 57(1):15-25. PubMed ID: 23070172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sequence motifs involved in Dengue virus-host interactions.
    Asnet Mary J; Paramasivan R; Shenbagarathai R
    J Biomol Struct Dyn; 2016; 34(3):676-87. PubMed ID: 25905427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y-Box Binding Protein 1 Interacts with Dengue Virus Nucleocapsid and Mediates Viral Assembly.
    Diosa-Toro M; Kennedy DR; Chuo V; Popov VL; Pompon J; Garcia-Blanco MA
    mBio; 2022 Feb; 13(1):e0019622. PubMed ID: 35189699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545.
    Modhiran N; Gandhi NS; Wimmer N; Cheung S; Stacey K; Young PR; Ferro V; Watterson D
    Antiviral Res; 2019 Aug; 168():121-127. PubMed ID: 31085206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors.
    Bardiot D; Koukni M; Smets W; Carlens G; McNaughton M; Kaptein S; Dallmeier K; Chaltin P; Neyts J; Marchand A
    J Med Chem; 2018 Sep; 61(18):8390-8401. PubMed ID: 30149709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biology of dengue virus enzymes: towards rational design of therapeutics.
    Noble CG; Shi PY
    Antiviral Res; 2012 Nov; 96(2):115-26. PubMed ID: 22995600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
    Lim SP; Noble CG; Seh CC; Soh TS; El Sahili A; Chan GK; Lescar J; Arora R; Benson T; Nilar S; Manjunatha U; Wan KF; Dong H; Xie X; Shi PY; Yokokawa F
    PLoS Pathog; 2016 Aug; 12(8):e1005737. PubMed ID: 27500641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for development of Dengue virus inhibitors.
    Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
    Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Dengue Virus NS4B Inhibitors.
    Wang QY; Dong H; Zou B; Karuna R; Wan KF; Zou J; Susila A; Yip A; Shan C; Yeo KL; Xu H; Ding M; Chan WL; Gu F; Seah PG; Liu W; Lakshminarayana SB; Kang C; Lescar J; Blasco F; Smith PW; Shi PY
    J Virol; 2015 Aug; 89(16):8233-44. PubMed ID: 26018165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.